ASC30
A Study to Evaluate the Efficacy, Safety, and Tolerability in Participants With Obesity or Overweight With Weight-Related Comorbidities
Ascletis Pharma (China) Co · Phase 2 · Completed · Enrollment 125
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.